NCT04746196View on ClinicalTrials.gov

Galectin-3 Level in Ankylosing Spondylitis Patients

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

June 30, 2017

Study Completion Date

August 30, 2017

Conditions
Ankylosing Spondylitis
Interventions
OTHER

Serum galectin-3 concentration was measured.

Serum galectin-3 concentration was measured using a commercial chemiluminescent microparticle immunoassay.

All Listed Sponsors
lead

Recep Tayyip Erdogan University Training and Research Hospital

OTHER

NCT04746196 - Galectin-3 Level in Ankylosing Spondylitis Patients | Biotech Hunter | Biotech Hunter